Thursday 27 October 2022

Anupam Rasayan India Limited Reports Q2FY23 Results

Q2FY23 Operating Revenue of ₹3,107 Mn; growth of 25% YoY

Q2FY23 EBITDA at ₹898 Mn; growth of 29% YoY

Q2FY23 EBITDA Margin at 29%; up 177 bps YoY 

Surat, October 27, 2022: Anupam Rasayan India Ltd. (BSE- 543275, NSE- ANURAS, ISIN: INE930P01018), one of India’s leading custom synthesis and specialty chemical player, has announced its financial results for the quarter ended September 30, 2022.

Standalone Financial Highlights for Quarter Ended September 30th , 2022:

▪ Operating Revenues at ₹3,107 million in Q2FY23 as compared to ₹2,489 million in Q2FY22 – growth of 25% Y-o-Y.

▪ Total Revenues at ₹3,087 million in Q2FY23 as compared to ₹2,552 million in Q2FY22 – growth of 21% Y-o-Y.

▪ EBITDA (incl. other revenue) at ₹898 million in Q2FY23 as compared to ₹697 million in Q2FY22 – growth of 29% Y-o-Y.

▪ Profit After Tax at ₹412 million in Q2FY23 as compared to ₹358 million in Q2FY22 - growth of 15% Y-o-Y.

Anand Desai, Managing Director of Anupam Rasayan, commented, “I am delighted to inform you that our standalone business grew by 25% year on year to Rs. 310cr. with with the consistent EBITDA margins.

Our philosophy of carrying a long-term vision in our business conduct is bearing its fruits as Anupam has started seeing the benefits of this Europe+1 trend with our latest announcement of signing two contracts with one of the European Crop Protection company for supplying two new life science related specialty chemicals.

Overall, we continue to see upward bias in all the contracted volumes with major customers. This makes us confident of delivering a strong performance in the coming quarters and for the year.”

About Anupam Rasayan India Ltd. (ARIL):

Anupam Rasayan India Ltd (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Incorporated in 1984, the speciality chemicals major has two verticals: Life science related Specialty Chemicals comprising products related to Agrochemicals, Personal Care and Pharmaceuticals, Other Specialty Chemicals comprising Specialty Pigment and Dyes, and Polymer Additives. The Company caters to a diverse base of Indian and global customers. It is currently manufacturing products for over 68 domestic and international customers, including 25 multinational companies. The Company operates via its six manufacturing facilities in Gujarat, India, with four facilities located at Sachin, Surat and two located at Jhagadia, Bharuch with an aggregate installed capacity of about 27,000 MT, as of 31st March 31, 2022. ARIL offers multistep synthesis and undertakes complex chemical reactions technologies, for a diverse base of Indian and global customers.

No comments:

Post a Comment